Comparative functional genomics analysis of NNK tobacco-carcinogen induced lung adenocarcinoma development in Gprc5a-knockout mice

PLoS ONE

Volumn 5, Issue 7, 2010, Pages

  Fujimoto, Junya ^a   Kadara, Humam ^a   Men, Taoyan ^a   van Pelt, Carolyn ^a   Lotan, Dafna ^a   Lotan, Reuben ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; CYCLIN D1; FLAP ENDONUCLEASE; FLAP STRUCTURE SPECIFIC ENDONUCLEASE 1; G PROTEIN COUPLED RECEPTOR KINASE 5; G PROTEIN COUPLED RECEPTOR KINASE 5A; MINICHROMOSOME MAINTENANCE PROTEIN 2; TRANSCRIPTOME; UBIQUITIN CONJUGATING ENZYME E2; UBIQUITIN CONJUGATING ENZYME E2C; UNCLASSIFIED DRUG; 4-(N-METHYL-N-NITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE; CARCINOGEN; G PROTEIN COUPLED RECEPTOR; NITROSAMINE; NUCLEAR PROTEIN; UBIQUITIN CONJUGATING ENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL FUNCTION; CONTROLLED STUDY; FEMALE; FUNCTIONAL GENOMICS; GENE EXPRESSION; GENETIC ANALYSIS; IMMUNOHISTOCHEMISTRY; LATENT PERIOD; LUNG ADENOCARCINOMA; LUNG ADENOMA; LUNG ALVEOLUS EPITHELIUM; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; TISSUE MICROARRAY; TUMOR VOLUME; UPREGULATION; VALIDATION PROCESS; WESTERN BLOTTING; ADENOCARCINOMA; ANIMAL; DNA MICROARRAY; GENETICS; GENOMICS; HUMAN; IN VITRO STUDY; LUNG TUMOR; METABOLISM; METHODOLOGY; MOUSE MUTANT; PHYSIOLOGY;

ANIMALIA; MUS; NICOTIANA TABACUM;

ADENOCARCINOMA; ANIMALS; BLOTTING, WESTERN; CARCINOGENS; CYCLIN D1; FLAP ENDONUCLEASES; GENOMICS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MICE; MICE, KNOCKOUT; NITROSAMINES; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, G-PROTEIN-COUPLED; UBIQUITIN-CONJUGATING ENZYMES;

EID: 77955597989     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011847     Document Type: Article

References (40)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
2. Herbst RS, HeymachJV, Lippman SM (2008) Lung cancer. N EnglJ Med 359: 1367-1380.
3. Gabrielson E (2006) Worldwide trends in lung cancer pathology. Respirology 11: 533-538.
4. Sun S, Schiller JH, Gazdar AF (2007) Lung cancer in never smokers-a different disease. Nat Rev Cancer 7: 778-790.
5. Steiling K, Ryan J, BrodyJS, Spira A (2008) The field of tissue injury in the lung and airway. Cancer Prev Res (Phila Pa) 1: 396-403.
6. Jacks T (2005) Modeling cancer in the mouse. Harvey Lect 101: 1-19.
7. Kassie F, Matise I, Negia M, Upadhyaya P, Hecht SS (2008) Dose-dependent inhibition of tobacco smoke carcinogen-induced lung tumorigenesis in A/J mice by indole-3-carbinol. Cancer Prev Res (Phila Pa) 1: 568-576.
8. Lantry LE, Zhang Z, Crist KA, Wang Y, Kelloff GJ, et al. (1999) 5-Aza-2′-deoxycytidine is chemopreventive in a 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone-induced primary mouse lung tumor model. Carcinogenesis 20: 343-346.
9. Lu Y, Yao R, Yan Y, Wang Y, Hara Y, et al. (2006) A gene expression signature that can predict green tea exposure and chemopreventive efficacy of lung cancer in mice. Cancer Res 66: 1956-1963.
10. Sabourin CL, Wang QS, Ralston SL, Evans J, CoateJ, et al. (1998) Expression of cell cycle proteins in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumors. Exp Lung Res 24: 499-521.
11. You M, Candrian U, Maronpot RR, Stoner GD, Anderson MW (1989) Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. Proc Natl Acad Sci U S A 86: 3070-3074.
12. Zhang Z, Liu Q, Lantry LE, Wang Y, Kelloff G J, et al. (2000) A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin. Cancer Res 60: 901-907.
13. Balansky R, Ganchev G, Iltcheva M, Steele VE, De Flora S. Prevention of cigarette smoke-induced lung tumors in mice by budesonide, phenethy lisothiocyanate, and N-acetylcysteine. Int J Cancer 126: 1047-1054.
14. D'Agostini F, Mastracci L, Izzotti A, Balansky R, Pennisi TM, et al. (2009) Modulation by phenethyl isothiocyanate and budesonide of molecular and histopathologic alterations induced by environmental cigarette smoke in mice. Cancer Prev Res (Phila Pa) 2: 546-556.
15. Hecht SS (2005) Carcinogenicity studies ofinhaled cigarette smoke in laboratory animals: old and new. Carcinogenesis 26: 1488-1492.
16. Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, et al. (2001) Somatic activation ofthe K-ras oncogene causes early onset lung cancer in mice. Nature 410: 1111-1116.
17. Ji H, Li D, Chen L, Shimamura T, Kobayashi S, et al. (2006) The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies. Cancer Cell 9: 485-495.
18. Li D, Shimamura T, Ji H, Chen L, Haringsma HJ, et al. (2007) Bronchial and peripheral murine lung carcinomas induced by T790M-L858R mutant EGFR respond to HKI-272 and rapamycin combination therapy. Cancer Cell 12: 81-93.
19. Zhang Z, Wang Y, Vikis HG, Johnson L, Liu G, et al. (2001) Wildtype Kras2 can inhibit lung carcinogenesis in mice. Nat Genet 29: 25-33.
20. Tao Q, Fujimoto J, Men T, Ye X, Deng J, et al. (2007) Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene. J Natl Cancer Inst 99: 1668-1682.
21. Devereux TR, Belinsky SA, Maronpot RR, White CM, Hegi ME, et al. (1993) Comparison of pulmonary O6-methylguanine DNA adduct levels and Ki-ras activation in lung tumors from resistant and susceptible mouse strains. Mol Carcinog 8: 177-185.
22. Hollander MC, Balogh AR, Liwanag J, Han W, Linnoila R I, et al. (2008) Strain-specific spontaneous and NNK-mediated tumorigenesis in Pten+/- mice. Neoplasia 10: 866-872.
23. Hecht SS, Morse MA, Amin S, Stoner GD, Jordan KG, et al. (1989) Rapid single-dose model for lung tumor induction in A/J mice by 4-(methylnitrosa-mino)-1-(3-pyridyl)-1-butanone and the effect of diet. Carcinogenesis 10: 1901-1904.
24. Nikitin AY, Alcaraz A, Anver MR, Bronson RT, Cardiff RD, et al. (2004) Classification ofproliferative pulmonary lesions ofthe mouse: recommendations of the mouse models of human cancers consortium. Cancer Res 64: 2307-2316.
25. Simon R, Lam A, Li MC, Ngan M, Menenzes S, et al. (2007) Analysis of Gene Expression Data Using BRB-Array Tools. Cancer Inform 3: 11-17.
26. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15.
27. Kadara H, Lacroix L, Behrens C, Solis L, Gu X, et al. (2009) Identification of gene signatures and molecular markers for human lung cancer prognosis using an in vitro lung carcinogenesis system. Cancer Prev Res (Phila Pa) 2: 702-711.
28. Klein-Szanto AJ, Iizasa T, Momiki S, Garcia-Palazzo I, Caamano J, et al. (1992) A tobacco-specific N-nitrosamine or cigarette smoke condensate causes neoplastic transformation of xenotransplanted human bronchial epithelial cells. Proc Natl Acad Sci U S A 89: 6693-6697.
29. Su LJ, Chang CW, Wu YC, Chen KC, Lin CJ, et al. (2007) Selection ofDDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme. BMC Genomics 8: 140.
30. Stearman RS, Dwyer-Nield L, Zerbe L, Blaine SA, Chan Z, et al. (2005) Analysis of orthologous gene expression between human pulmonary adenocar-cinoma and a carcinogen-induced murine model. Am JPathol 167: 1763-1775.
31. Sun SY, Li W, Yue P, Lippman SM, Hong WK, et al. (1999) Mediation of N-(4 hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms. Cancer Res 59: 2493-2498.
32. Liu P, Wang Y, Vikis H, Maciag A, Wang D, et al. (2006) Candidate lung tumor susceptibility genes identified through whole-genome association analyses in inbred mice. Nat Genet 38: 888-895.
33. Lu G, Liao J, Yang G, Reuhl KR, Hao X, et al. (2006) Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine. Cancer Res 66: 11494-11501.
34. Kaposi-Novak P, Lee JS, Gomez-Quiroz L, Coulouarn C, Factor VM, et al. (2006) Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. J Clin Invest 116: 1582-1595.
35. Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, et al. (2006) A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med 12: 410-416.
36. Bennett CN, Green JE (2008) Unlocking the power of cross-species genomic analyses: dentification of evolutionarily conserved breast cancer networks and validation of preclinical models. Breast Cancer Res 10: 213.
37. Okamoto Y, Ozaki T, Miyazaki K, Aoyama M, Miyazaki M, et al. (2003) UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme. Cancer Res 63: 4167-4173.
38. Ramnath N, Hernandez FJ, Tan DF, Huberman JA, Natarajan N, et al. (2001) MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer. J Clin Oncol 19: 4259-266.
39. Tan DF, Huberman JA, Hyland A, Loewen GM, Brooks JS, et al. (2001) MCM2-a promising marker for premalignant lesions of the lung: a cohort study. BMC Cancer 1: 6.
40. Sato M, Girard L, Sekine I, Sunaga N, Ramirez RD, et al. (2003) Increased expression and no mutation of the Flap endonuclease (FEN1) gene in human lung cancer. Oncogene 22: 7243-7246.